KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX)

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / COMMON STOCK
Total 13F shares
92,009,907
Share change
-1,666,192
Total reported value
$918,210,256
Put/Call ratio
69%
Price per share
$9.98
Number of holders
148
Value change
-$41,707,073
Number of buys
84
Number of sells
66

Institutional Holders of KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) as of Q2 2015

As of 30 Jun 2015, KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) was held by 148 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 92,009,907 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, FMR LLC, STATE STREET CORP, OAK RIDGE INVESTMENTS LLC, Brandywine Global Investment Management, LLC, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, and Apex Capital Management. This page lists 148 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.